Quantcast

Olmesartan-associated severe gastritis and enteropathy.

Research paper by Lavanya L Shenbagaraj, Gillian G Swift

Indexed on: 21 Dec '18Published on: 21 Dec '18Published in: BMJ case reports



Abstract

Olmesartan is an angiotensin II receptor antagonist, used in the treatment of hypertension. We report a case of olmesartan-associated severe gastritis with enteropathy in a 74-year-old woman who presented with mainly upper gastrointestinal symptoms. There was significant endoscopic improvement in the mucosal inflammation on stopping the drug. Subsequent gastroscopy showed mucosal healing and normal gastric and duodenal mucosa. To our knowledge, this is the first case report of olmesartan-associated gastritis and enteropathy predominantly involving and affecting the whole of stomach with limited small bowel involvement. © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.